235 related articles for article (PubMed ID: 12713442)
21. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
22. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
23. High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents.
Huang KS; Holmgren J; Reik L; Lucas-McGady D; Roberts J; Liu CM; Levin W
Anal Biochem; 2004 Oct; 333(2):389-98. PubMed ID: 15450817
[TBL] [Abstract][Full Text] [Related]
24. Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase.
Lai NS; Simizu S; Morisaki D; Muroi M; Osada H
Exp Cell Res; 2008 Sep; 314(15):2834-45. PubMed ID: 18662687
[TBL] [Abstract][Full Text] [Related]
25. Processing and activation of latent heparanase occurs in lysosomes.
Zetser A; Levy-Adam F; Kaplan V; Gingis-Velitski S; Bashenko Y; Schubert S; Flugelman MY; Vlodavsky I; Ilan N
J Cell Sci; 2004 May; 117(Pt 11):2249-58. PubMed ID: 15126626
[TBL] [Abstract][Full Text] [Related]
26. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
27. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
28. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
29. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
30. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
31. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member.
McKenzie E; Tyson K; Stamps A; Smith P; Turner P; Barry R; Hircock M; Patel S; Barry E; Stubberfield C; Terrett J; Page M
Biochem Biophys Res Commun; 2000 Oct; 276(3):1170-7. PubMed ID: 11027606
[TBL] [Abstract][Full Text] [Related]
32. Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization.
Haining RL; Hunter AP; Sadeque AJ; Philpot RM; Rettie AE
Drug Metab Dispos; 1997 Jul; 25(7):790-7. PubMed ID: 9224773
[TBL] [Abstract][Full Text] [Related]
33. Bacterial expression and functional reconstitution of human heparanase.
Winkler S; Schweiger D; Wei Z; Rajkovic E; Kungl AJ
Carbohydr Res; 2014 May; 389():72-7. PubMed ID: 24656445
[TBL] [Abstract][Full Text] [Related]
34. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
35. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
Hershkovitz O; Jarahian M; Zilka A; Bar-Ilan A; Landau G; Jivov S; Tekoah Y; Glicklis R; Gallagher JT; Hoffmann SC; Zer H; Mandelboim O; Watzl C; Momburg F; Porgador A
Glycobiology; 2008 Jan; 18(1):28-41. PubMed ID: 18006589
[TBL] [Abstract][Full Text] [Related]
36. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
37. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
38. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
39. Heparanase coagulation and cancer progression.
Nadir Y; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
[TBL] [Abstract][Full Text] [Related]
40. Functional reconstitution of an active recombinant human chymase from Pichia pastoris cell lysate.
Nakakubo H; Morita M; Imada T; Takai S; Shiota N; Miyazaki M; Nakamura N
Yeast; 2000 Nov; 16(15):1387-96. PubMed ID: 11054819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
